Technology News and Research

RSS

Viewpoints: Romney praises Israeli health care system -- which has an individual mandate; Sebelius and Pelosi hail launch of women's preventive care provisions

At a breakfast fundraiser in Jerusalem on Monday, (Republican presidential candidate Mitt Romney) had nothing but nice things to say about our ally. But in flattering Israel, he raised more doubts about his political abilities. ... he also praised Israel's health care system. "Do you realize what health care spending is as a percentage of the GDP in Israel?" he asked.

2 Aug 2012

Cervical cancer screening product from DySIS Medical recommended by NICE

DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE’) has today published positive diagnostics guidance recommending its DySIS cervical cancer screening product to be considered in procurement plans.

1 Aug 2012

Intraluminal protection device outperforms two negative-pressure IV connectors in MECH research

An IV connector known as an intraluminal protection device (IPD) significantly outperformed two widely used negative-pressure IV connectors in research performed at Methodist Extended Care Hospital (MECH).

1 Aug 2012

Poor sleep can reduce effectiveness of vaccines

As moms have always known, a good night's sleep is crucial to good health -- and now a new study led by a UCSF researcher shows that poor sleep can reduce the effectiveness of vaccines.

1 Aug 2012

Biomimetic bioartificial livers and cell toxicity assays: an interview with Dr. Joris Braspenning, CEO Medicyte

Biomimetic bioartificial livers are liver organoids based on synthetic equivalents of the human extracellular matrix (ECM) which will be seeded with human cells.

1 Aug 2012

Bristol-Myers Squibb, Prosetta partner to discover and develop new antiviral drugs

Prosetta Antiviral Inc today announced the execution of a strategic alliance with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs.

31 Jul 2012

GE Healthcare, Intermountain partner to help reduce radiation dose in CT procedures by 50%

Intermountain Healthcare today announced a joint effort with GE Healthcare to help further reduce radiation dose in Computed Tomography (CT) procedures at its facilities by up to 50 percent.

31 Jul 2012

FDA clears Reflectance Medical's CareGuide Oximeter

Reflectance Medical, a commercial-stage company focused on the development of physiologic sensors to non-invasively and continuously assess patient metabolic status, announced today that it has received FDA 510(k) clearance for its initial product, the CareGuide Oximeter.

31 Jul 2012

NYGC purchases four Life Technologies' Ion Proton Sequencers

Life Technologies Corporation today announced that the New York Genome Center (NYGC) has purchased four Ion Proton Sequencers for its new Innovation Center.

31 Jul 2012

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).

31 Jul 2012

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

InSite Vision Incorporated today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite (ISV-303) for the reduction of pain and inflammation after cataract surgery.

31 Jul 2012

Rye Radiology offers new 3D mammography that detects many breast cancers

Rye Radiology Associates, LLP, became the first facility between Manhattan and Syracuse to offer the new FDA-approved 3D mammography which finds more breast cancers than traditional mammography.

31 Jul 2012

Australia's top medical researchers for 2012 announced

Finalists for one of Australia’s longest running and most prestigious awards for medical research were announced today. This year’s winner will join a list of alumni winners that includes many of the country’s most respected scientists.

31 Jul 2012

Population Genetics validates GenomePooling™ for cancer

Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue. This validates the method’s suitability for use in IntReALL 2010, the world’s largest genetic analysis of acute lymphoblastic leukaemia (ALL) relapse cases. ALL is the most common childhood malignant disease.

31 Jul 2012

ICF receives IDIQ contract to conduct pilot and evaluation studies, statistical analysis and TTA

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Department of Health and Human Services (HHS), Substance Abuse and Mental Health Services Administration (SAMHSA) to conduct pilot and evaluation studies, statistical analysis, and training and technical assistance (TTA).

31 Jul 2012

GenomePooling™ method is sensitive and accurate

31 Jul 2012

MEDNAX acquires Loudoun Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Loudoun Anesthesia Associates, a physician group practice that provides anesthesia services at Inova Loudoun Hospital and Inova Loudoun Ambulatory Surgery Center in Leesburg, Va.

31 Jul 2012

Aetna reports net income of $457.6 million for second-quarter 2012

Aetna today announced second-quarter 2012 operating earnings of $452.0 million, or $1.31 per share, compared to the $1.35 per share reported in the second quarter of 2011.

31 Jul 2012

Astronics announces acquisition of Max-Viz

Astronics Corporation, a leading provider of advanced technologies for the global aerospace and defense industries, today announced that it has acquired privately-held Max-Viz, Inc., a market-leading developer and designer of Enhanced Vision Systems (EVS) for fixed and rotary wing aircraft through both OEM and aftermarket channels in the general aviation, commercial and military aerospace markets for $10 million in cash.

31 Jul 2012

VA releases PE Coach mobile app for use with PTSD treatment

The Departments of Defense and Veterans Affairs have released PE (for prolonged exposure) Coach, a smartphone mobile application for use with post-traumatic stress disorder treatment. Both departments use prolonged exposure therapy as an effective treatment for PTSD. PE Coach is a free app for Apple and Android mobile devices.

31 Jul 2012